Sanofi Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Sanofi stocks.

Sanofi Stocks Recent News

Date Stock Title
Mar 28 MRK Looking At Merck & Co's Recent Unusual Options Activity
Mar 28 MRK Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Mar 28 MRK How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together
Mar 28 REGN Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Mar 28 EXEL Insiders Are Dumping These 10 Healthcare Stocks
Mar 28 REGN Stock-Split Watch: Are These 2 Top Growth Stocks Next?
Mar 28 MRK Company News for Mar 28, 2024
Mar 28 MRK European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
Mar 28 REGN Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
Mar 27 MRK US STOCKS-Stocks close with gains, led by Dow as investors look for rate insight
Mar 27 MACK Merrimack receives $225M milestone payment from Ipsen
Mar 27 MACK Merrimack Receives $225 Million Milestone Payment from Ipsen
Mar 27 MRK US STOCKS-Stocks gain, led by Dow as investors look for rate insight
Mar 27 MRK Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook
Mar 27 MRK US STOCKS-Dow leads gains on Wall Street as investors await rate clues
Mar 27 MRK Merck's Future Brightens With Winrevair's Blockbuster Potential
Mar 27 MRK FDA approves Merck treatment for lung disease, potential path to upside
Mar 27 MRK Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck
Mar 27 MRK US STOCKS-Dow leads Wall St higher in lean trading week
Mar 27 MRK Merck Drug for Rare Form of High Blood Pressure Gets US Nod
Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

Browse All Tags